IMS Company Profiles - Report Buyer

IMS COM PANY PRO FILES NOVARTIS SUBSIDIARY LISTING
Ther a peu tic Classes (% of Sales by Lead ing
5): 60-65%
Dose Forms (% of Sales by Lead ing 5):
85-90%
Prin ci pal Prod ucts:
VOLTAREN NV- (antirheumatic top i cal; an al ge sic
non-nar cotic)
FENISTIL (antipruritic; an ti his ta mine sys temic)
OTRIVEN (NVR) (na sal prep a ra tion top i cal)
LAMISIL NV- (dermatological antifungal)
NICOTINELL (antismoking prod uct)
Ther a peu tic Range:
anti rheu ma tics top i cal 34%
na sal prep a ra tions 10%
an al ge sics 9%
antipruritics 6%
dermatological antifungals 6%
Lead ing Dose Forms:
gels/sols 40%
liq uids 16%
coated tab lets 14%
creams 9%
spe cial solid forms 7%
SALUTAS
Full Name: SALUTAS Pharma GmbH
Street Ad dress: Otto-von-Guericke Allee 1,
D-39179 Barleben
Tel: +49 392 03 710
Fax: +49 392 03 71-77 70
Home Page: www.salutas.de
De scrip tion: Man u fac turer, de vel oper, ex porter,
dis trib u tor, pro moter. Prod uct ranges in clude:
phar ma ceu ti cal prod ucts (branded, pre scrip tion),
hos pi tal pharmaceuticals, in ter me di ates.
Established 1886.
Con tacts (Pharm): Com mer cial Op er a tions: Ms
Schlosner; Re search & De vel op ment: Dr
Hans-Joachim Runge
Par ent of: Hexal, In do ne sia (6%).
Sub sid iary of: Novartis, Swit zer land
SANDOZ
Full Name: Sandoz In ter na tional GmbH
Street Ad dress: Industriestrasse 25, D-83607
Holzkirchen
Tel: +49 8024 908-0
Fax: +49 8024 908-1290
Email: info.sandoz@sandoz.com
Home Page: www.sandoz.de
De scrip tion: Re searcher, de vel oper, man u fac -
turer, for mu la tor, packager/as sem bler, im porter,
ex porter, dis trib u tor, pro moter, sales/detailer.
De vel ops, man u fac tures, dis trib utes, ex ports,
pro motes, sells/de tails for other com pa nies. Prod -
uct ranges in clude: phar ma ceu ti cal prod ucts
(branded, unbranded, pre scrip tion, non-pre scrip -
tion), hos pi tal pharmaceuticals, fine chem i cals,
raw ma te ri als, bi o log i cal prod ucts, bio tech nol ogy
prod ucts, di ag nos tic prod ucts, di etetic/nu tri tional
prod ucts, herbal prod ucts, oph thal mic products,
veterinary pharmaceuticals. Established 1986.
Con tacts (Pharm): Chair man: Dr Andreas
Struengmann, Dr Thomas Struengmann; Com -
mer cial Op er a tions: Mr Mayr; Man u fac ture: Dr K.
Klokkers; Mar ket Re search: Mr Spaeth; Re search
& De vel op ment: Dr Andreas Struengmann, Dr P.
Schoetter, Dr Schaefer; Gen eral Con tact: Dr
Andreas Struengmann, Dr Thomas Struengmann
Par ent of: Hexal, China (joint); G-Gam, France
(100%); Novexal, Greece; Hexal, In do ne sia
(94%); Rowex, Ire land (joint); Hexal, Rus sia
(100%); Hexal, South Af rica (100%); Bexal,
Spain; Ilsan Ilac, Tur key (100%).
Sub sid iary of: Novartis, Swit zer land (100%)
Phar ma ceu ti cal Sales: US$ 1,500-1,600 mil -
lion
Prod ucts (% of Sales by Lead ing 5): 25-30%
Ther a peu tic Classes (% of Sales by Lead ing
5): 40-45%
Dose Forms (% of Sales by Lead ing 5):
90-95%
Prin ci pal Prod ucts:
OMEP (antiulcerant)
SIMVAHEXAL (cho les terol/triglyceride reg u lat ing
prep a ra tion)
FENTANYL-HEX.BET.M (an al ge sic nar cotic; an es -
thetic gen eral)
METOHEXAL SUCC (beta-blocker agent plain)
GINGIUM (ce re bral/pe riph eral vasotherapeutic)
Ther a peu tic Range:
an al ge sics 12%
ant ac ids/antiflatulents/antiulcerants 11%
beta-block ing agents 8%
lipid-reg u lat ing/antiatheroma prep a ra tions 7%
renin-an gio ten sin sys tem agents 7%
Lead ing Dose Forms:
tab lets 37%
coated tab lets 29%
cap sules 16%
med i cal dress ings 6%
liq uids 3%
SANDOZ PHARMA
Full Name: Sandoz Pharmaceuticals GmbH
© 2009 IMS Health In cor po rated or its af fil i ates Page 172